AU2021304479A1 - Compositions and methods useful for the prevention and/or treatment of disease in mammals - Google Patents

Compositions and methods useful for the prevention and/or treatment of disease in mammals Download PDF

Info

Publication number
AU2021304479A1
AU2021304479A1 AU2021304479A AU2021304479A AU2021304479A1 AU 2021304479 A1 AU2021304479 A1 AU 2021304479A1 AU 2021304479 A AU2021304479 A AU 2021304479A AU 2021304479 A AU2021304479 A AU 2021304479A AU 2021304479 A1 AU2021304479 A1 AU 2021304479A1
Authority
AU
Australia
Prior art keywords
ksp37
protein
viral
subject
kda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021304479A
Other languages
English (en)
Inventor
Michelle Olga Patricia Giesteira Da Silva SMIT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viro Gen Pty Ltd
Original Assignee
Viro Gen Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viro Gen Pty Ltd filed Critical Viro Gen Pty Ltd
Publication of AU2021304479A1 publication Critical patent/AU2021304479A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00113—Growth factors
    • A61K39/001132—Fibroblast growth factors [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2021304479A 2020-07-09 2021-07-09 Compositions and methods useful for the prevention and/or treatment of disease in mammals Pending AU2021304479A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ZA2020/04008 2020-07-09
ZA2020/03850 2020-07-09
ZA202003850 2020-07-09
ZA202004008 2020-07-09
PCT/IB2021/056179 WO2022009165A1 (en) 2020-07-09 2021-07-09 Compositions and methods useful for the prevention and/or treatment of disease in mammals

Publications (1)

Publication Number Publication Date
AU2021304479A1 true AU2021304479A1 (en) 2023-01-19

Family

ID=79552952

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021304479A Pending AU2021304479A1 (en) 2020-07-09 2021-07-09 Compositions and methods useful for the prevention and/or treatment of disease in mammals

Country Status (16)

Country Link
US (1) US20240091310A1 (https=)
EP (1) EP4178604A4 (https=)
JP (1) JP2023533162A (https=)
KR (1) KR20230038230A (https=)
CN (1) CN115720520A (https=)
AU (1) AU2021304479A1 (https=)
BR (1) BR112022026874A2 (https=)
CA (1) CA3179965A1 (https=)
CL (1) CL2023000073A1 (https=)
CO (1) CO2022019251A2 (https=)
IL (1) IL299661A (https=)
MX (1) MX2023000113A (https=)
PE (1) PE20231554A1 (https=)
PH (1) PH12023550038A1 (https=)
WO (1) WO2022009165A1 (https=)
ZA (1) ZA202213371B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025215561A1 (en) * 2024-04-09 2025-10-16 Viro-Gen (Pty) Ltd Plasmid for expression of ksp37
WO2025221871A1 (en) * 2024-04-16 2025-10-23 The Trustees Of Columbia University In The City Of New York Expansion, propagation, and modulation of immune cell subsets by peptides
WO2025233868A1 (en) * 2024-05-07 2025-11-13 Viro-Gen (Pty) Ltd Compounds, compositions and methods for treating, reversing or preventing cancer
WO2025233869A1 (en) * 2024-05-07 2025-11-13 Viro-Gen (Pty) Ltd Compounds, compositions and methods for treating, reversing or preventing type 2 diabetes mellitus

Also Published As

Publication number Publication date
JP2023533162A (ja) 2023-08-02
EP4178604A4 (en) 2024-07-31
PH12023550038A1 (en) 2024-03-11
KR20230038230A (ko) 2023-03-17
WO2022009165A1 (en) 2022-01-13
IL299661A (en) 2023-03-01
BR112022026874A2 (pt) 2023-01-24
CA3179965A1 (en) 2022-01-13
PE20231554A1 (es) 2023-10-03
MX2023000113A (es) 2023-03-16
EP4178604A1 (en) 2023-05-17
ZA202213371B (en) 2023-11-29
CO2022019251A2 (es) 2023-03-27
CN115720520A (zh) 2023-02-28
US20240091310A1 (en) 2024-03-21
CL2023000073A1 (es) 2023-07-07

Similar Documents

Publication Publication Date Title
US20240091310A1 (en) Compositions and methods useful for the prevention and/or treatment of disease in mammals
JP7551157B2 (ja) Ｈｉｖワクチン接種および免疫療法
JP7162895B2 (ja) Ｈｉｖ予備免疫化および免疫療法
JP7260170B2 (ja) 事前の免疫化ステップのないｈｉｖ免疫療法
JP2019517503A (ja) 遺伝子編集戦略によるｈｉｖ−１のネガティブフィードバック調節
CN110770338A (zh) 由人γ-δ T细胞激活肿瘤细胞毒性的方法和组合物
JP2018524335A (ja) Ｈｉｖ予備免疫化および免疫療法
US20240141374A1 (en) On demand expression of exogenous factors in lymphocytes
OA21071A (en) Compositions and methods useful for the prevention and/or treatment of disease in mammals.
WO2025064901A2 (en) Hiv vaccination and immunotherapy
WO2024218154A1 (en) Nucleic acid vaccine for activating nkg2c+ natural killer cells